# Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary Syndrome

> **NCT06823830** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 105 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Jinfeng Pill

## Key facts

- **NCT ID:** NCT06823830
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06823830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06823830, "Clinical、metabolomics and the Study of Intestinal Flora of Jinfeng Pills in the Treatment of Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06823830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*